Yung WK - Search Results

1

Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.

Koul D, Fu J, Shen R, LaFortune TA, Wang S, Tiao N, Kim YW, Liu JL, Ramnarian D, Yuan Y, Garcia-Echevrria C, Maira SM, Yung WK. Koul D, et al. Among authors: yung wk. Clin Cancer Res. 2012 Jan 1;18(1):184-95. doi: 10.1158/1078-0432.CCR-11-1558. Epub 2011 Nov 7. Clin Cancer Res. 2012. PMID: 22065080 Free PMC article.

2

Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region.

Sheng X, Koul D, Liu JL, Liu TJ, Yung WK. Sheng X, et al. Among authors: yung wk. Biochem Biophys Res Commun. 2002 Mar 29;292(2):422-6. doi: 10.1006/bbrc.2002.6662. Biochem Biophys Res Commun. 2002. PMID: 11906179

3

VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.

Ke LD, Shi YX, Yung WK. Ke LD, et al. Among authors: yung wk. Cancer Res. 2002 Mar 15;62(6):1854-61. Cancer Res. 2002. PMID: 11912165

4

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.

Koul D, Jasser SA, Lu Y, Davies MA, Shen R, Shi Y, Mills GB, Yung WK. Koul D, et al. Among authors: yung wk. Oncogene. 2002 Apr 4;21(15):2357-64. doi: 10.1038/sj.onc.1205296. Oncogene. 2002. PMID: 11948419

5

MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.

Koul D, Shen R, Garyali A, Ke LD, Liu TJ, Yung WK. Koul D, et al. Among authors: yung wk. Int J Oncol. 2002 Sep;21(3):469-75. Int J Oncol. 2002. PMID: 12168088

6

Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.

Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA, Yung WK. Gomez-Manzano C, et al. Among authors: yung wk. Ann Neurol. 2003 Jan;53(1):109-17. doi: 10.1002/ana.10396. Ann Neurol. 2003. PMID: 12509854

7

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.

Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW. Levin VA, et al. Among authors: yung wk. Clin Cancer Res. 2003 Mar;9(3):981-90. Clin Cancer Res. 2003. PMID: 12631596 Clinical Trial.

8

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Lang FF, et al. Among authors: yung wk. J Clin Oncol. 2003 Jul 1;21(13):2508-18. doi: 10.1200/JCO.2003.21.13.2508. J Clin Oncol. 2003. PMID: 12839017 Clinical Trial.

9

Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.

Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Lu Y, et al. Among authors: yung wk. J Biol Chem. 2003 Oct 10;278(41):40057-66. doi: 10.1074/jbc.M303621200. Epub 2003 Jul 17. J Biol Chem. 2003. PMID: 12869565 Free article.

10

The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival.

Zhou YH, Tan F, Hess KR, Yung WK. Zhou YH, et al. Among authors: yung wk. Clin Cancer Res. 2003 Aug 15;9(9):3369-75. Clin Cancer Res. 2003. PMID: 12960124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters